. "Krej\u010D\u00ED, Marta" . "Szturz, Petr" . "58" . . "We observed an excellent effect of lenalidomide in multifocal aggressive, repeatedly relapsing Langerhans cell histiocytosis where it led to cWe observed an excellent effect of lenalidomide in multifocal aggressive, repeatedly relapsing Langerhans cell histiocytosis where it led to complete remission. We showed an effect of lenalidomide in Langerhans cell histiocytosis and in Castleman disease. The treatment led to regression of brain infiltrates in a patient with Erdheim-Chester disease. A dose of 10 mg of lenalidomide daily in combination with 50 mg of thalidomide stabilized a course of angiomatosis. Lenalidomide did not deliver the required treatment response in a patient with POEMS syndrome and multiple previous therapies.omplete remission. We showed an effect of lenalidomide in Langerhans cell histiocytosis and in Castleman disease. The treatment led to regression of brain infiltrates in a patient with Erdheim-Chester disease. A dose of 10 mg of lenalidomide daily in combination with 50 mg of thalidomide stabilized a course of angiomatosis. Lenalidomide did not deliver the required treatment response in a patient with POEMS syndrome and multiple previous therapies."@en . "Kr\u00E1l, Zden\u011Bk" . "lenalidomide"@en . "175659" . "Nebesk\u00FD, Tom\u00E1\u0161" . . "Vnit\u0159n\u00ED l\u00E9ka\u0159stv\u00ED" . "The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis"@en . . "\u00DA\u010Dinnost lenalidomidu u vz\u00E1cn\u00FDch krevn\u00EDch chorob: u histiocyt\u00F3zy z Langerhansov\u00FDch bun\u011Bk, multicentrick\u00E9 Castlemanovy choroby, POMS syndromu, Erdheimovy-Chesterovy choroby a angiomatozy. Popis p\u0159\u00EDpad\u016F a p\u0159ehled literatury" . "RIV/65269705:_____/12:#0001609" . "10"^^ . "Pour, Lud\u011Bk" . "\u00DA\u010Dinnost lenalidomidu u vz\u00E1cn\u00FDch krevn\u00EDch chorob: u histiocyt\u00F3zy z Langerhansov\u00FDch bun\u011Bk, multicentrick\u00E9 Castlemanovy choroby, POMS syndromu, Erdheimovy-Chesterovy choroby a angiomatozy. Popis p\u0159\u00EDpad\u016F a p\u0159ehled literatury"@cs . "[9A07A1450BEE]" . . . "Adam, Zden\u011Bk" . . "RIV/65269705:_____/12:#0001609!RIV13-MZ0-65269705" . . "The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis"@en . "Mayer, Ji\u0159\u00ED" . . . . "0042-773X" . "V t\u00E9to pr\u00E1ci sumarizujeme na\u0161e zku\u0161enosti s \u00FA\u010Dinnost\u00ED lenalidomidu u vz\u00E1cn\u00FDch krevn\u00EDch chorob. Prok\u00E1zali jsme \u00FA\u010Dinek lenalidomidu u histiocyt\u00F3zy z Langerhansov\u00FDch bun\u011Bk a u Castlemanovy nemoci. U Erdheimovy-Chesterovy nemoci vymizely v pr\u016Fb\u011Bhu l\u00E9\u010Dby infiltr\u00E1ty v mozku. Lenalidomid v d\u00E1vce 10 mg denn\u011B v kombinaci s 50 mg thalidomidu stabilizoval pr\u016Fb\u011Bh angiomat\u00F3zy. Pouze u pacientky s POEMS syndromem a \u010Detn\u00FDmi p\u0159edchoz\u00EDmi l\u00E9\u010Debn\u00FDmi liniemi nenavodil lenalidomid o\u010Dek\u00E1vanou l\u00E9\u010Debnou odpov\u011B\u010F." . . "11"^^ . "Zahradov\u00E1, Lenka" . . "\u00DA\u010Dinnost lenalidomidu u vz\u00E1cn\u00FDch krevn\u00EDch chorob: u histiocyt\u00F3zy z Langerhansov\u00FDch bun\u011Bk, multicentrick\u00E9 Castlemanovy choroby, POMS syndromu, Erdheimovy-Chesterovy choroby a angiomatozy. Popis p\u0159\u00EDpad\u016F a p\u0159ehled literatury" . . "9"^^ . . "I, P(NT11154), P(NT12130), P(NT12215)" . . "CZ - \u010Cesk\u00E1 republika" . "11" . "V t\u00E9to pr\u00E1ci sumarizujeme na\u0161e zku\u0161enosti s \u00FA\u010Dinnost\u00ED lenalidomidu u vz\u00E1cn\u00FDch krevn\u00EDch chorob. Prok\u00E1zali jsme \u00FA\u010Dinek lenalidomidu u histiocyt\u00F3zy z Langerhansov\u00FDch bun\u011Bk a u Castlemanovy nemoci. U Erdheimovy-Chesterovy nemoci vymizely v pr\u016Fb\u011Bhu l\u00E9\u010Dby infiltr\u00E1ty v mozku. Lenalidomid v d\u00E1vce 10 mg denn\u011B v kombinaci s 50 mg thalidomidu stabilizoval pr\u016Fb\u011Bh angiomat\u00F3zy. Pouze u pacientky s POEMS syndromem a \u010Detn\u00FDmi p\u0159edchoz\u00EDmi l\u00E9\u010Debn\u00FDmi liniemi nenavodil lenalidomid o\u010Dek\u00E1vanou l\u00E9\u010Debnou odpov\u011B\u010F."@cs . "H\u00E1jek, Roman" . . . . "\u00DA\u010Dinnost lenalidomidu u vz\u00E1cn\u00FDch krevn\u00EDch chorob: u histiocyt\u00F3zy z Langerhansov\u00FDch bun\u011Bk, multicentrick\u00E9 Castlemanovy choroby, POMS syndromu, Erdheimovy-Chesterovy choroby a angiomatozy. Popis p\u0159\u00EDpad\u016F a p\u0159ehled literatury"@cs . . . . . . .